In the article cited above, the duality of interest for author Emily B. Schroeder reads “E.B.S. received industry-sponsored research support from Novartis, Merck Sharpe & Dohme, Boehringer Ingelheim, AstraZeneca, and Bristol-Myers Squibb.” The author has requested that this be corrected to read “E.B.S. was supported by National Institute of Diabetes and Digestive and Kidney Diseases grant K23DK099237.”

The online version has been corrected to reflect this change.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.